发明名称 |
Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor |
摘要 |
<p>Disclosed is the use of a compound of formula 1, or a pharmaceutically acceptable salt or solvate thereof, or a mixture thereof, in an amount from 1 to 48 mg/m2 free base, together with an anti-cancer agent chosen from gemcitabine, 6-thioguanine, doxorubicin, cisplatin, irinotecan, and temozolomide, for treating cancer in a mammal. Also disclosed is the use of a compound of formula 1, or a pharmaceutically acceptable salt or solvate thereof, or a mixture thereof, in an amount from 2 to 96 mg free base, together with an anti-cancer agent chosen from the same list as above, for treating cancer in a mammal. Also disclosed is a method for treating cancer in a non-human mammal comprising administering a compound of formula 1 or a pharmaceutically acceptable salt or solvate thereof, or a mixture thereof, in an amount effective to provide a sustained plasma concentration value of at least 5.9 ng/mL for at least 24 after administration, in combination with an anti-cancer agent as described above or a dose of radiation.</p> |
申请公布号 |
NZ553295(A) |
申请公布日期 |
2010.04.30 |
申请号 |
NZ20050553295 |
申请日期 |
2005.09.09 |
申请人 |
PFIZER INC.;CANCER RESEARCH TECHNOLOGY LTD. |
发明人 |
STEINFELDT, HEIDI MARIE;BORITZKI, THEODORE JAMES;CALVERT, ALAN HILARY;CURTIN, NICOLA JANE;DEWJI, MOHAMED RAZA;HOSTOMSKY, ZDENEK;JONES, CHRISTOPHER;KAUFMAN, RHONDA;KLAMERUS, KAREN J;NEWELL, DAVID RICHARD;PLUMMER, ELIZABETH RUTH;REICH, STEVEN DAVID;STRATFORD, IAN J;THOMAS, HUW DAVID;WILLIAMS, KAYE JANINE |
分类号 |
A61K31/282;A61K31/4188;A61K31/4745;A61K31/513;A61K31/519;A61K31/55;A61K31/704;A61K33/24;A61P35/00 |
主分类号 |
A61K31/282 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|